−1.18SEK
−44.61 MSEK
1.36 MSEK
53.58 M
About ENORAMA PHARMA AB
Sector
CEO
Annette Agerskov
Headquarters
Malmö
Website
Founded
2006
ISIN
SE0008216329
FIGI
BBG00CVRYPV2
Enorama Pharma AB engages in the research, development and manufacture of pharmaceutical drug delivery system. It offers medicated chewing gums for people having difficulty swallowing tablets or who may have various problems with digestion. The company was founded by Mats-Olle Rönngard on November 28, 2006 and is headquartered in Malmo, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ERMA is 2.45 SEK — it has decreased by 5.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ENORAMA PHARMA AB stocks are traded under the ticker ERMA.
ERMA stock is 10.20% volatile and has beta coefficient of 1.81. Check out the list of the most volatile stocks — is ENORAMA PHARMA AB there?
Yes, you can track ENORAMA PHARMA AB financials in yearly and quarterly reports right on TradingView.
ERMA stock has fallen by 29.60% compared to the previous week, the month change is a 35.53% fall, over the last year ENORAMA PHARMA AB has showed a 27.81% decrease.
ERMA net income for the last quarter is −13.75 M SEK, while the quarter before that showed −12.99 M SEK of net income which accounts for −5.86% change. Track more ENORAMA PHARMA AB financial stats to get the full picture.
Today ENORAMA PHARMA AB has the market capitalization of 138.89 M, it has increased by 1.38% over the last week.
No, ERMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ERMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENORAMA PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENORAMA PHARMA AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENORAMA PHARMA AB stock shows the sell signal. See more of ENORAMA PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENORAMA PHARMA AB EBITDA is −38.29 M SEK, and current EBITDA margin is −2.82 K%. See more stats in ENORAMA PHARMA AB financial statements.